Article Versions Notes

Alomar FA, Tian C, Bidasee SR, Venn ZL, Schroder E, Palermo NY, AlShabeeb M, Edagwa BJ, Payne JJ, Bidasee KR. HIV-Tat Exacerbates the Actions of Atazanavir, Efavirenz, and Ritonavir on Cardiac Ryanodine Receptor (RyR2). International Journal of Molecular Sciences. 2023; 24(1):274. https://doi.org/10.3390/ijms24010274

Alomar, Fadhel A., Chengju Tian, Sean R. Bidasee, Zachary L. Venn, Evan Schroder, Nicholas Y. Palermo, Mohammad AlShabeeb, Benson J. Edagwa, Jason J. Payne, and Keshore R. Bidasee. 2023. "HIV-Tat Exacerbates the Actions of Atazanavir, Efavirenz, and Ritonavir on Cardiac Ryanodine Receptor (RyR2)" International Journal of Molecular Sciences 24, no. 1: 274. https://doi.org/10.3390/ijms24010274

Alomar, F. A., Tian, C., Bidasee, S. R., Venn, Z. L., Schroder, E., Palermo, N. Y., AlShabeeb, M., Edagwa, B. J., Payne, J. J., & Bidasee, K. R. (2023). HIV-Tat Exacerbates the Actions of Atazanavir, Efavirenz, and Ritonavir on Cardiac Ryanodine Receptor (RyR2). International Journal of Molecular Sciences, 24(1), 274. https://doi.org/10.3390/ijms24010274